Magnetic nanoparticles for magnetic drug targeting

References

[1] Al Faraj A, Shaik AP, Shaik AS. Magnetic single-walled carbon nanotubes as efficient drug delivery nanocarriers in breast cancer murine model: noninvasive monitoring using diffusion-weighted magnetic resonance imaging as sensitive imaging biomarker. Int J Nanomed 2015; 10: 157–168.Search in Google Scholar

[2] Alexiou C, Diehl D, Henninger P, et al. A high field gradient magnet for magnetic drug targeting. IEEE Trans Appl Supercond 2006; 16: 1527–1530.10.1109/TASC.2005.864457Search in Google Scholar

[3] Alexiou C, Schmidt A, Klein R, Hulin P, Bergemann C, Arnold W. Magnetic drug targeting: biodistribution and dependency on magnetic field strength. J Magn Magn Mater 2002; 252: 363–366.10.1016/S0304-8853(02)00605-4Search in Google Scholar

[4] Alexiou C, Tietze R, Schreiber E, et al. Cancer therapy with drug loaded magnetic nanoparticles-magnetic drug targeting. J Magn Magn Mater 2011; 323: 1404–1407.10.1016/j.jmmm.2010.11.059Search in Google Scholar

[5] Amara D, Felner I, Nowik I, Margel S. Synthesis and characterization of Fe and Fe3O4 nanoparticles by thermal decomposition of triiron dodecacarbonyl. Colloids Surf A Physicochem Eng Asp 2009; 339: 106–110.10.1016/j.colsurfa.2009.02.003Search in Google Scholar

[6] Arruebo M, Fernandez-Pacheco R, Ibarra MR, Santamaria J. Magnetic nanoparticles for drug delivery. Nano Today 2007; 2: 22–32.10.1016/S1748-0132(07)70084-1Search in Google Scholar

[7] Avdeev MV, Bica D, Vekas L, et al. On the possibility of using short chain length mono-carboxylic acids for stabilization of magnetic fluids. J Magn Magn Mater 2007; 311: 6–9.10.1016/j.jmmm.2006.11.155Search in Google Scholar

[8] Ayres LR, de Almeida Campos MS, de Oliveira Gozzo T, et al. Trastuzumab induced cardiotoxicity in HER2 positive breast cancer patients attended in a tertiary hospital. Int J Clin Pharm 2015; 37: 365–372.10.1007/s11096-015-0070-ySearch in Google Scholar

[9] Babincova M, Altanerova V, Altaner C, Bergemann C, Babinec P. In vitro analysis of cisplatin functionalized magnetic nanoparticles in combined cancer chemotherapy and electromagnetic hyperthermia. IEEE Trans Nanobioscience 2008; 7: 15–19.10.1109/TNB.2008.2000145Search in Google Scholar

[10] Bica D, Vekas L, Avdeev MV, et al. Sterically stabilized water based magnetic fluids: synthesis, structure and properties. J Magn Magn Mater 2007; 311: 17–21.10.1016/j.jmmm.2006.11.158Search in Google Scholar

[11] Brigger I, Dubernet C, Couvreur P. Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliv Rev 2002; 54: 631–651.10.1016/S0169-409X(02)00044-3Search in Google Scholar

[12] Bruners P, Braunschweig T, Hodenius M, et al. Thermoablation of malignant kidney tumors using magnetic nanoparticles: an in vivo feasibility study in a rabbit model. Cardiovasc Interv Radiol 2010; 33: 127–134.10.1007/s00270-009-9583-xSearch in Google Scholar

[13] Cao QL, Han XT, Li LA. Enhancement of the efficiency of magnetic targeting for drug delivery: development and evaluation of magnet system. J Magn Magn Mater 2011; 323: 1919–1924.10.1016/j.jmmm.2010.11.058Search in Google Scholar

[14] Chen Q, Rondinone AJ, Chakoumakos BC, Zhang ZJ. Synthesis of superparamagnetic MgFe2O4 nanoparticles by coprecipitation. J Magn Magn Mater 1999; 194: 1–7.10.1016/S0304-8853(98)00585-XSearch in Google Scholar

[15] Cherry EM, Eaton JK. A comprehensive model of magnetic particle motion during magnetic drug targeting. Int J Multiphas Flow 2014; 59: 173–185.10.1016/j.ijmultiphaseflow.2013.11.007Search in Google Scholar

[16] Cherry EM, Maxim PG, Eaton JK. Particle size, magnetic field, and blood velocity effects on particle retention in magnetic drug targeting. Med Phys 2010; 37: 175–182.10.1118/1.3271344Search in Google Scholar PubMed

[17] Chertok B, Moffat BA, David AE, et al. Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors. Biomaterials 2008; 29: 487–496.10.1016/j.biomaterials.2007.08.050Search in Google Scholar PubMed PubMed Central

[18] Danhier F, Feron O, Preat V. To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J Control Release 2010; 148: 135–146.10.1016/j.jconrel.2010.08.027Search in Google Scholar PubMed

[19] David AE, Cole AJ, Chertok B, Park YS, Yang VC. A combined theoretical and in vitro modeling approach for predicting the magnetic capture and retention of magnetic nanoparticles in vivo. J Control Release 2011; 152: 67–75.10.1016/j.jconrel.2011.01.033Search in Google Scholar PubMed PubMed Central

[20] Durr S, Janko C, Lyer S, et al. Magnetic nanoparticles for cancer therapy. Nanotechnol Rev 2013; 2: 395–409.10.1515/ntrev-2013-0011Search in Google Scholar

[21] Dutz S, Andrae W, Hergt R, et al. Influence of dextran coating on the magnetic behaviour of iron oxide nanoparticles. J Magn Magn Mater 2007; 311: 51–54.10.1016/j.jmmm.2006.11.168Search in Google Scholar

[22] Dutz S, Kettering M, Hilger I, Muller R, Zeisberger M. Magnetic multicore nanoparticles for hyperthermia-influence of particle immobilization in tumour tissue on magnetic properties. Nanotechnology 2011; 22(26): 265102–265109.10.1088/0957-4484/22/26/265102Search in Google Scholar PubMed

[23] Eberbeck D, Bergemann C, Hartwig S, Steinhoff U, Trahms L. Binding kinetics of magnetic nanoparticles on latex beads and yeast cells studied by magnetorelaxometry. J Magn Magn Mater 2005; 289: 435–438.10.1016/j.jmmm.2004.11.122Search in Google Scholar

[24] Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 2013; 49: 1374–1403.10.1016/j.ejca.2012.12.027Search in Google Scholar PubMed

[25] Fortin JP, Wilhelm C, Servais J, Menager C, Bacri JC, Gazeau F. Size-sorted anionic iron oxide nanomagnets as colloidal mediators for magnetic hyperthermia. J Am Chem Soc 2007; 129: 2628–2635.10.1021/ja067457eSearch in Google Scholar PubMed

[26] Georgiadou V, Kokotidou C, Le Droumaguet B, Carbonnier B, Choli-Papadopoulou T, Dendrinou-Samara C. Oleylamine as a beneficial agent for the synthesis of CoFe(2)O(4) nanoparticles with potential biomedical uses. Dalton Trans (Cambridge, England: 2003) 2014; 43: 6377–6388.10.1039/C3DT53179ASearch in Google Scholar

[27] Gitter K, Odenbach S. Quantitative targeting maps based on experimental investigations for a branched tube model in magnetic drug targeting. J Magn Magn Mater 2011; 323: 3038–3042.10.1016/j.jmmm.2011.06.055Search in Google Scholar

[28] Gitter K, Odenbach S. Investigations on a branched tube model in magnetic drug targeting-systematic measurements and simulation. IEEE Trans Magn 2013; 49: 343–348.10.1109/TMAG.2012.2224324Search in Google Scholar

[29] Gleich B, Hellwig N, Bridell H, et al. Design and evaluation of magnetic fields for nanoparticle drug targeting in cancer. IEEE Trans Nanotechnol 2007; 6:164–170.10.1109/TNANO.2007.891829Search in Google Scholar

[30] Globocan 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. [http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx].Search in Google Scholar

[31] Gunduz U, Keskin T, Tansik G, et al. Idarubicin-loaded folic acid conjugated magnetic nanoparticles as a targetable drug delivery system for breast cancer. Biomed Pharmacother 2014; 68: 729–736.10.1016/j.biopha.2014.08.013Search in Google Scholar PubMed

[32] Gupta AK, Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 2005; 26: 3995–4021.10.1016/j.biomaterials.2004.10.012Search in Google Scholar PubMed

[33] Gupta AK, Wells S. Surface-modified superparamagnetic nanoparticles for drug delivery: Preparation, characterization, and cytotoxicity studies. IEEE Trans Nanobioscience 2004; 3: 66–73.10.1109/TNB.2003.820277Search in Google Scholar

[34] Hajshafiei P, Fatahian S, Shahanipoor K. In vivo toxicity assessment of bovine serum albumin and dimercaptosuccinic acid coated Fe3O4 nanoparticles. Iran J Biotech 2014; 12: e16858.10.5812/ijb.16858Search in Google Scholar

[35] Han XT, Cao QL, Li L. Design and evaluation of three-dimensional electromagnetic guide system for magnetic drug delivery. IEEE Trans Appl Supercond 2012; 22: 4401404–4401408.10.1109/TASC.2011.2176456Search in Google Scholar

[36] Harisinghani MG, Barentsz J, Hahn PF, et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 2003; 348: 2491–2499.10.1056/NEJMoa022749Search in Google Scholar PubMed

[37] Heidsieck A, Vosen S, Zimmermann K, Wenzel D, Gleich B. Analysis of trajectories for targeting of magnetic nanoparticles in blood vessels. Mol Pharm 2012; 9: 2029–2038.10.1021/mp3001155Search in Google Scholar PubMed

[38] Heilmaier C, Lutz AM, Bolog N, Weishaupt D, Seifert B, Willmann JK. Focal liver lesions: detection and characterization at double-contrast liver MR imaging with ferucarbotran and gadobutrol versus single-contrast liver MR imaging. Radiology 2009; 253: 724–733.10.1148/radiol.2533090161Search in Google Scholar PubMed

[39] Hilton JE, McMurry SM. An adjustable linear Halbach array. J Magn Magn Mater 2012; 324: 2051–2056.10.1016/j.jmmm.2012.02.014Search in Google Scholar

[40] Huang X, Yi C, Fan Y, et al. Magnetic Fe(3) O (4) nanoparticles grafted with single-chain antibody (scFv) and docetaxel loaded beta-cyclodextrin potential for ovarian cancer dual-targeting therapy. Mater Sci Engineering C Mater Biol Appl 2014; 42: 325–332.10.1016/j.msec.2014.05.041Search in Google Scholar PubMed

[41] Huang ZY, Pei N, Wang YY, et al. Deep magnetic capture of magnetically loaded cells for spatially targeted therapeutics. Biomaterials 2010; 31: 2130–2140.10.1016/j.biomaterials.2009.11.062Search in Google Scholar PubMed

[42] Hwu JR, Lin YS, Josephrajan T, et al. Targeted Paclitaxel by conjugation to iron oxide and gold nanoparticles. J Am Chem Soc 2009; 131: 66–68.10.1021/ja804947uSearch in Google Scholar PubMed

[43] Jalalian SH, Taghdisi SM, Hamedani NS, et al. Epirubicin loaded super paramagnetic iron oxide nanoparticle-aptamer bioconjugate for combined colon cancer therapy and imaging in vivo. Eur J Pharm Sci 2013; 50: 191–197.10.1016/j.ejps.2013.06.015Search in Google Scholar

[44] Jordan A, Scholz R, Wust P, et al. Endocytosis of dextran and silan-coated magnetite nanoparticles and the effect of intracellular hyperthermia on human mammary carcinoma cells in vitro. J Magn Magn Mater 1999; 194: 185–196.10.1016/S0304-8853(98)00558-7Search in Google Scholar

[45] Jurgons R, Seliger C, Hilpert A, Trahms L, Odenbach S, Alexiou C. Drug loaded magnetic nanoparticles for cancer therapy. J Phys Condens Matter 2006; 18: S2893–S2902.10.1088/0953-8984/18/38/S24Search in Google Scholar

[46] Khalafalla SE, Reimers GW. Preparation of dilution-stable aqueous magnetic fluids. IEEE Trans Magn 1980; 16: 178–183.10.1109/TMAG.1980.1060578Search in Google Scholar

[47] Khanna RA, Anger C. Patterns of patients stopping their anti-cancer drug due to its associated side effects in France, Germany, Italy, Spain and UK (EU5). In: ESMO 2014. Spain: Madrid, 2014.Search in Google Scholar

[48] Khatiri R, Reyhani A, Mortazavi SZ, Hossainalipour M. Immobilization of serum albumin on the synthesized three layers core-shell structures of super-paramagnetic iron oxide nanoparticles. J Ind Eng Chem 2013; 19: 1642–1647.10.1016/j.jiec.2013.02.002Search in Google Scholar

[49] Khodadust R, Unsoy G, Gunduz U. Development of poly (I:C) modified doxorubicin loaded magnetic dendrimer nanoparticles for targeted combination therapy. Biomed Pharmacother 2014; 68: 979–987.10.1016/j.biopha.2014.10.009Search in Google Scholar

[50] Kim YI, Kim D, Lee CS. Synthesis and characterization of CoFe2O4 magnetic nanoparticles prepared by temperature-controlled coprecipitation method. Physica B Condens Matter 2003; 337: 42–51.10.1016/S0921-4526(03)00322-3Search in Google Scholar

[51] Kohler N, Sun C, Wang J, Zhang MQ. Methotrexate-modified superparamagnetic nanoparticles and their intracellular uptake into human cancer cells. Langmuir 2005; 21: 8858–8864.10.1021/la0503451Search in Google Scholar PubMed

[52] Kratz H, Eberbeck D, Wagner S, Taupitz M, Schnorr J. Synthetic routes to magnetic nanoparticles for MPI. Biomed Eng-Biomed Tech 2013; 58: 509–515.10.1515/bmt-2012-0057Search in Google Scholar PubMed

[53] Laurent S, Dutz S, Hafeli UO, Mahmoudi M. Magnetic fluid hyperthermia: focus on superparamagnetic iron oxide nanoparticles. Adv Colloid Interfac 2011; 166: 8–23.10.1016/j.cis.2011.04.003Search in Google Scholar PubMed

[54] Laurent S, Saei AA, Behzadi S, Panahifar A, Mahmoudi M. Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges. Exp Opin Drug Deliv 2014; 11: 1449–1470.10.1517/17425247.2014.924501Search in Google Scholar PubMed

[55] Lee IJ, Ahn CH, Cha EJ, Chung IJ, Chung JW, Kim YI. Improved drug targeting to liver tumors after intra-arterial delivery using superparamagnetic iron oxide and iodized oil preclinical study in a rabbit model. Invest Radiol 2013; 48: 826–833.10.1097/RLI.0b013e31829c13efSearch in Google Scholar PubMed

[56] Lin M, Huang J, Sha M. Recent advances in nanosized Mn-Zn ferrite magnetic fluid hyperthermia for cancer treatment. J Nanosci Nanotechnol 2014; 14: 792–802.10.1166/jnn.2014.9135Search in Google Scholar PubMed

[57] Lonning PE, Knappskog S. Mapping genetic alterations causing chemoresistance in cancer: identifying the roads by tracking the drivers. Oncogene 2013; 32: 5315–5330.10.1038/onc.2013.48Search in Google Scholar PubMed

[58] Lyer S, Tietze R, Duerr S, et al. Diagnostic imaging in cancer therapy with magnetic nanoparticles. In: Buzug B, editor. 2nd workshop on magnetic particle imaging IWMPI 2012. Lübeck: Springer 2012: 197–201.Search in Google Scholar

[59] Lyer S, Tietze R, Jurgons R, et al. Distribution of magnetic nanoparticles after magnetic drug targeting in an ex vivo bovine artery model. In: Dössel O, editor. World Congress 2009. Munich: SWC 2009: 484–487.10.1007/978-3-642-03885-3_134Search in Google Scholar

[60] Lyer S, Tietze R, Jurgons R, et al. Visualisation of tumour regression after local chemotherapy with magnetic nanoparticles – a pilot study. Anticancer Res 2010; 30: 1553–1557.Search in Google Scholar

[61] Maity D, Kale SN, Kaul-Ghanekar R, Xue JM, Ding J. Studies of magnetite nanoparticles synthesized by thermal decomposition of iron (III) acetylacetonate in tri(ethylene glycol). J Magn Magn Mater 2009; 321: 3093–3098.10.1016/j.jmmm.2009.05.020Search in Google Scholar

[62] Majd MH, Asgari D, Barar J, et al. Specific targeting of cancer cells by multifunctional mitoxantrone-conjugated magnetic nanoparticles. J Drug Target 2013; 21: 328–340.10.3109/1061186X.2012.750325Search in Google Scholar PubMed

[63] Matuszak J, Zaloga J, Friedrich RP, et al. Endothelial biocompatibility and accumulation of SPION under flow conditions. J Magn Magn Mater 2015; 380: 20–26.10.1016/j.jmmm.2014.09.005Search in Google Scholar

[64] Mehta DA, Hay JW. Cost-effectiveness of adding bevacizumab to first line therapy for patients with advanced ovarian cancer. Gynecol Oncol 2014; 132: 677–683.10.1016/j.ygyno.2014.01.021Search in Google Scholar PubMed

[65] Meidanchi A, Akhavan O, Khoei S, Shokri AA, Hajikarimi Z, Khansari N. ZnFe2O4 nanoparticles as radiosensitizers in radiotherapy of human prostate cancer cells. Mater Sci Eng C Mater Biol Appl 2015; 46: 394–399.10.1016/j.msec.2014.10.062Search in Google Scholar PubMed

[66] Nacev A, Komaee A, Sarwar A, et al. Towards control of magnetic fluids in patients directing therapeutic nanoparticles to disease locations. IEEE Control Syst Mag 2012; 32: 32–74.10.1109/MCS.2012.2189052Search in Google Scholar

[67] Orel V, Shevchenko A, Romanov A, et al. Magnetic properties and antitumor effect of nanocomplexes of iron oxide and doxorubicin. Nanomedicine 2015; 11: 47–55.10.1016/j.nano.2014.07.007Search in Google Scholar PubMed

[68] Pankhurst QA, Connolly J, Jones SK, Dobson J. Applications of magnetic nanoparticles in biomedicine. J Phys D Appl Phys 2003; 36: R167–R181.10.1088/0022-3727/36/13/201Search in Google Scholar

[69] Pereira C, Pereira AM, Fernandes C, et al. Superparamagnetic MFe2O4 (M=Fe, Co, Mn) nanoparticles: tuning the particle size and magnetic properties through a novel one-step coprecipitation route. Chem Mater 2012; 24: 1496–1504.10.1021/cm300301cSearch in Google Scholar

[70] Pernia Leal M, Rivera-Fernandez S, Franco JM, Pozo D, de la Fuente JM, Garcia-Martin ML. Long-circulating PEGylated manganese ferrite nanoparticles for MRI-based molecular imaging. Nanoscale 2015; 7: 2050–2059.10.1039/C4NR05781CSearch in Google Scholar

[71] Popovici E, Dumitrache F, Morjan I, et al. Iron/iron oxides core-shell nanoparticles by laser pyrolysis: structural characterization and enhanced particle dispersion. Appl Surf Sci 2007; 254: 1048–1052.10.1016/j.apsusc.2007.09.022Search in Google Scholar

[72] Rahn H, Gomez-Morilla I, Jurgons R, Alexiou C, Eberbeck D, Odenbach S. Tomographic examination of magnetic nanoparticles used as drug carriers. J Magn Magn Mater 2009; 321: 1517–1520.10.1016/j.jmmm.2009.02.078Search in Google Scholar

[73] Rahn H, Odenbach S. X-ray microcomputed tomography as a tool for the investigation of the biodistribution of magnetic nanoparticles. Nanomedicine 2009; 4: 981–990.10.2217/nnm.09.82Search in Google Scholar PubMed

[74] Rajpure KY. Exploring structural and magnetic properties of nanocrystalline iron oxide synthesized by autocombustion method. Superlattices Microstruct 2015; 77: 181–195.10.1016/j.spmi.2014.11.012Search in Google Scholar

[75] Ramesh R, Ponnusamy S, Muthamizhchelvan C. Synthesis, properties and heating characteristics of bovine serum albumin coated Fe3O4 magnetic fluid for magnetic fluid hyperthermia application. Sci Adv Mater 2013; 5: 1250–1255.10.1166/sam.2013.1579Search in Google Scholar

[76] Rao YF, Chen W, Liang XG, et al. Epirubicin-loaded superparamagnetic iron-oxide nanoparticles for transdermal delivery: cancer therapy by circumventing the skin barrier. Small. Germany: Weinheim an der Bergstrasse 2015; 11: 239–247.Search in Google Scholar

[77] Richter H, Wiekhorst F, Schwarz K, et al. Magnetorelaxometric quantification of magnetic nanoparticles in an artery model after ex vivo magnetic drug targeting. Phys Med Biol 2009; 54: N417–N424.10.1088/0031-9155/54/18/N03Search in Google Scholar PubMed

[78] Sadighian S, Rostamizadeh K, Hosseini-Monfared H, Hamidi M. Doxorubicin-conjugated core-shell magnetite nanoparticles as dual-targeting carriers for anticancer drug delivery. Colloids Surf B Biointerfaces 2014; 117: 406–413.10.1016/j.colsurfb.2014.03.001Search in Google Scholar PubMed

[79] Santra S, Tapec R, Theodoropoulou N, Dobson J, Hebard A, Tan WH. Synthesis and characterization of silica-coated iron oxide nanoparticles in microemulsion: The effect of nonionic surfactants. Langmuir 2001; 17: 2900–2906.10.1021/la0008636Search in Google Scholar

[80] Sarwar A, Nemirovski A, Shapiro B. Optimal Halbach permanent magnet designs for maximally pulling and pushing nanoparticles. J Magn Magn Mater 2012; 324: 742–754.10.1016/j.jmmm.2011.09.008Search in Google Scholar PubMed PubMed Central

[81] Scharlach C, Kratz H, Wiekhorst F, et al. Synthesis of acid-stabilized iron oxide nanoparticles and comparison for targeting atherosclerotic plaques: evaluation by MRI, quantitative MPS, and TEM alternative to ambiguous Prussian blue iron staining. Nanomedicine 2015; 11: 1085–1095.10.1016/j.nano.2015.01.002Search in Google Scholar PubMed

[82] Schuetz CA, Juillerat-Jeanneret L, Mueller H, Lynch I, Riediker M. NanoImpactNet C: therapeutic nanoparticles in clinics and under clinical evaluation. Nanomedicine 2013; 8: 449–467.10.2217/nnm.13.8Search in Google Scholar PubMed

[83] Seliger C, Jurgons R, Wiekhorst F, et al. In vitro investigation of the behaviour of magnetic particles by a circulating artery model. J Magn Magn Mater 2007; 311: 358–362.10.1016/j.jmmm.2006.10.1205Search in Google Scholar

[84] Singh A, Sahoo SK. Magnetic nanoparticles: a novel platform for cancer theranostics. Drug Discov Today 2014; 19: 474–481.10.1016/j.drudis.2013.10.005Search in Google Scholar PubMed

[85] Singh D, McMillan JM, Kabanov AV, Sokolsky-Papkov M, Gendelman HE. Bench-to-bedside translation of magnetic nanoparticles. Nanomedicine (London, England) 2014; 9: 501–516.10.2217/nnm.14.5Search in Google Scholar

[86] Tehrani MD, Kim MO, Yoon J. A novel electromagnetic actuation system for magnetic nanoparticle guidance in blood vessels. IEEE Trans Magn 2014; 50: 5100412–5100423.10.1109/TMAG.2014.2307271Search in Google Scholar

[87] Tian Y, Jiang X, Chen X, Shao Z, Yang W. Doxorubicin-loaded magnetic silk fibroin nanoparticles for targeted therapy of multidrug-resistant cancer. Adv Mater (Deerfield Beach, Fla) 2014; 26: 7393–7398.10.1002/adma.201403562Search in Google Scholar PubMed

[88] Tietze R, Jurgons R, Lyer S, et al. Quantification of drug-loaded magnetic nanoparticles in rabbit liver and tumor after in vivo administration. J Magn Magn Mater 2009; 321: 1465–1468.10.1016/j.jmmm.2009.02.068Search in Google Scholar

[89] Tietze R, Lyer S, Durr S, et al. Efficient drug-delivery using magnetic nanoparticles – biodistribution and therapeutic effects in tumour bearing rabbits. Nanomed-Nanotechnol 2013; 9: 961–971.10.1016/j.nano.2013.05.001Search in Google Scholar PubMed

[90] Tietze R, Rahn H, Lyer S, et al. Visualization of superparamagnetic nanoparticles in vascular tissue using X mu CT and histology. Histochem Cell Biol 2011; 135: 153–158.10.1007/s00418-011-0780-8Search in Google Scholar PubMed

[91] Tietze R, Schreiber E, Lyer S, Alexiou C. Mitoxantrone loaded superparamagnetic nanoparticles for drug targeting: a versatile and sensitive method for quantification of drug enrichment in rabbit tissues using HPLC-UV. J Biomed Biotechnol 2010; 2010: 597304.10.1155/2010/597304Search in Google Scholar PubMed PubMed Central

[92] Tombacz E, Bica D, Hajdu A, Illes E, Majzik A, Vekas L. Surfactant double layer stabilized magnetic nanofluids for biomedical application. J Phys Condens Matter 2008; 20: 204103.10.1088/0953-8984/20/20/204103Search in Google Scholar PubMed

[93] Unsoy G, Khodadust R, Yalcin S, Mutlu P, Gunduz U. Synthesis of Doxorubicin loaded magnetic chitosan nanoparticles for pH responsive targeted drug delivery. Eur J Pharm Sci 2014; 62: 243–250.10.1016/j.ejps.2014.05.021Search in Google Scholar PubMed

[94] Unterweger H, Tietze R, Janko C, et al. Development and characterization of magnetic iron oxide nanoparticles with a cisplatin-bearing polymer coating for targeted drug delivery. Int J Nanomed 2014; 9: 3659–3676.10.2147/IJN.S63433Search in Google Scholar PubMed PubMed Central

[95] Wiekhorst F, Liebl M, Steinhoff U, et al. Magnetorelacometry for in-vivo quantification of magnetic nanoparticle distributions after magnetic drug targeting in a rabbit carcinoma model. In: Buzug editor. 2nd international workshop on magnetic particle imaging IWMPI 2012; Lübeck, Germany: Springer; 2012: 301–305.10.1007/978-3-642-24133-8_48Search in Google Scholar

[96] Yang G, Zhang BL, Wang J, Xie SB, Li X. Preparation of polylysine-modified superparamagnetic iron oxide nanoparticles. J Magn Magn Mater 2015; 374: 205–208.10.1016/j.jmmm.2014.08.040Search in Google Scholar

[97] Yang GX, He F, Lv RC, et al. A cheap and facile route to synthesize monodisperse magnetic nanocrystals and their application as MRI agents. Dalton Trans 2015; 44: 247–253.10.1039/C4DT02425GSearch in Google Scholar PubMed

[98] Ye H, Tong J, Wu J, et al. Preclinical evaluation of recombinant human IFN alpha(2)b-containing magnetoliposomes for treating hepatocellular carcinoma. Int J Nanomed 2014; 9: 4533–4550.Search in Google Scholar

[99] Zaloga J, Janko C, Nowak J, et al. Development of a lauric acid/albumin hybrid iron oxide nanoparticle system with improved biocompatibility. Int J Nanomed 2014; 9: 4847–4866.10.2147/IJN.S68539Search in Google Scholar PubMed PubMed Central

[100] Zhang SP, Dong DW, Sui Y, et al. Preparation of core shell particles consisting of cobalt ferrite and silica by sol-gel process. J Alloys Compd 2006; 415: 257–260.10.1016/j.jallcom.2005.07.048Search in Google Scholar

[101] Zou Y, Liu P, Liu CH, Zhi XT. Doxorubicin-loaded mesoporous magnetic nanoparticles to induce apoptosis in breast cancer cells. Biomed Pharmacother 2015; 69: 355–360.10.1016/j.biopha.2014.12.012Search in Google Scholar PubMed